not tagged
CEL-SCI
['head and neck', '$cvm', 'cel-sci']
$cvm cel-sci s phase 3 data presented at esmo 2022: neoadjuvant multikine achieved groundbreaking tumor response &amp; extended overall survival in locally advanced head and neck cancer #cancer
Free Stock Market News are delayed 15 sec. Full features and live news available here: https://t.co/fWRacb3Vft